TriSalus Life Sciences Enrolls First Patient in PERIO-02 Clinical Trial, Studyin

This topic has 0 replies, 1 voice, and was last updated 2 years, 6 months ago by gavin.

Viewing 1 post (of 1 total)

Author

Posts
May 10, 2022 at 9:55 pm #101665

gavin
Moderator

TriSalus Life Sciences Enrolls First Patient in PERIO-02 Clinical Trial, Studying the Delivery of SD-101 via Pressure-Enabled Drug Delivery in Adults with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

https://www.businesswire.com/news/home/20220510005227/en/TriSalus-Life-Sciences-Enrolls-First-Patient-in-PERIO-02-Clinical-Trial-Studying-the-Delivery-of-SD-101-via-Pressure-Enabled-Drug-Delivery-in-Adults-with-Hepatocellular-Carcinoma-or-Intrahepatic-Cholangiocarcinoma/?feedref=JjAwJuNHiystnCoBq_hl-W8j9Oi60kFTomUxRDB8jhBsNpnJw7dvSfTyni2BOVIOrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3nDlC87j5HoE75BMeA8LaVacVjEfZIyqgxRRsuxHCTK2w%3D%3D&utm_source=dlvr.it&utm_medium=twitter

Thanks to Businesswire for this piece.

Gavin
Author

Posts

Viewing 1 post (of 1 total)

The forum ‘Clinical Trials’ is closed to new topics and replies.

©2022 - All Rights Reserved, Cholangiocarcinoma Foundation